NEUROSURGERY Report

Daily news and updates provided by the NEUROSURGERY® Editorial Office

Free Editor Choice with CME: Transsphenoidal Surgery After Nondiagnostic IPSS

Background: Inferior petrosal sinus sampling (IPSS) is a useful technique for confirming a pituitary source of adrenocorticotropic hormone (ACTH) overproduction in Cushing disease. Uncertainty remains regarding the appropriate course of therapy when an ectopic tumor is predicted by IPSS but none can be found and in circumstances when the procedure cannot be successfully completed owing to technical or anatomic limitations.

Objective: To determine an appropriate course of action after nondiagnostic IPSS.

Methods: We reviewed 288 IPSS procedures in 283 patients between 1986 and 2010 at our center. An IPS:peripheral ACTH ratio ≥ 2 at baseline or ≥ 3 after corticotrophin-releasing hormone was considered predictive of a pituitary source of ACTH. A procedure was considered nondiagnostic if the procedure was successfully performed and the results predicted an ectopic source but none could be found despite extensive imaging or if the IPS could not be bilaterally cannulated because of technical difficulties or anatomic variants.

Results: The sensitivity, specificity, positive predictive value, and negative predictive value of IPSS for detecting a pituitary source in Cushing disease were 94%, 50%, 98%, and 29%, respectively. We identified 3 categories of nondiagnostic IPSS comprising 44 of the total procedures. These patients underwent exploratory transsphenoidal surgery, and in 42 of these patients (95%), a pituitary source was surgically proven, with a remission rate of 83%.

Conclusion: Transsphenoidal surgery should be considered in cases of ACTH-dependent Cushing disease and noncentralized or technically unsuccessful IPSS without evidence of ectopic tumor.

From: Transsphenoidal Surgery for Cushing Disease After Nondiagnostic Inferior Petrosal Sinus Sampling by Sheth et al.

Free full text access.

SANS Neurosurgery members can earn CME credits from this article.

Combining the power of neurosurgery’s most popular online learning resource with its most influential peer-reviewed journal, SANS Neurosurgery offers subscribers the resources to stay ahead in the rapidly moving field. Test your knowledge and neurosurgical decision-making skills with questions pulled from each issue of Neurosurgery. This SANS product provides users with the latest pearls and constantly evolving information from the latest scientific neurosurgery articles.

About these ads

Written by NEUROSURGERY® Editorial Office

June 26, 2012 at 9:24 AM

Follow

Get every new post delivered to your Inbox.

Join 9,811 other followers